Displaying 1 - 1 of 1
| Active Ingredient | BERACTANT |
| Therapeutic Class | PULMONARTY SURFCTANTS |
| Indications |
Treatment of respiratory distress syndrome in preterm neonates, birth-weight over 700g; prophylaxis of respiratory distress syndrome in preterm neonates less than 32 weeks corrected gestational age. |
| Caution | Intracranial haemorrhage. |
| Dose Range |
Respiratory distress syndrome: 100 mg/kg equivalent to a volume of 4 mL/kg, preferably within 8 hours of birth; dose may be repeated within 48 hours at intervals of at least 6 hours for up to 4 doses. Prophylaxis of respiratory distress syndrome: 100 mg/k |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |